Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Sonali Smith

Concepts (81)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Non-Hodgkin
6
2015
241
2.090
Why?
Lymphoma, Follicular
4
2017
62
1.890
Why?
Lymphoma, Mantle-Cell
3
2017
23
1.490
Why?
Antineoplastic Agents
6
2017
2093
1.410
Why?
Thalidomide
2
2017
54
1.190
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2017
1928
1.020
Why?
Lymphoma
3
2008
271
0.970
Why?
Stem Cell Transplantation
3
2006
154
0.950
Why?
Protein Kinase Inhibitors
3
2015
442
0.920
Why?
Quinazolinones
1
2017
11
0.800
Why?
Purines
1
2017
103
0.750
Why?
Molecular Targeted Therapy
2
2015
204
0.700
Why?
Hodgkin Disease
2
2013
153
0.640
Why?
TOR Serine-Threonine Kinases
2
2012
142
0.640
Why?
Sirolimus
2
2012
158
0.580
Why?
Maintenance Chemotherapy
1
2012
49
0.570
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
79
0.570
Why?
Drug Costs
1
2012
51
0.550
Why?
Cyclophosphamide
1
2009
264
0.450
Why?
Neoplasm Proteins
1
2012
475
0.440
Why?
Antineoplastic Agents, Alkylating
1
2009
135
0.440
Why?
Recurrence
5
2013
1065
0.440
Why?
Intracellular Signaling Peptides and Proteins
1
2010
318
0.420
Why?
Hematopoietic Stem Cell Transplantation
2
2013
650
0.390
Why?
Topotecan
1
2006
43
0.380
Why?
Protein-Serine-Threonine Kinases
1
2010
502
0.370
Why?
Doxorubicin
1
2006
271
0.350
Why?
Antibodies, Monoclonal
1
2013
1359
0.350
Why?
Salvage Therapy
1
2006
206
0.340
Why?
Transplantation Conditioning
1
2006
318
0.310
Why?
Remission Induction
3
2010
640
0.290
Why?
Immunosuppressive Agents
1
2008
936
0.270
Why?
Aged
7
2017
15532
0.270
Why?
Immunologic Factors
2
2015
124
0.260
Why?
Disease-Free Survival
3
2010
1119
0.260
Why?
Drug Administration Schedule
2
2017
905
0.260
Why?
Middle Aged
7
2017
21688
0.240
Why?
Humans
13
2017
69089
0.230
Why?
Treatment Outcome
4
2015
6420
0.230
Why?
Male
8
2017
35798
0.220
Why?
Treatment Failure
2
2009
269
0.210
Why?
Female
8
2017
37672
0.210
Why?
Maximum Tolerated Dose
1
2017
238
0.190
Why?
Adult
6
2013
22186
0.190
Why?
Survival Analysis
2
2009
1438
0.170
Why?
Histone Deacetylase Inhibitors
1
2015
67
0.170
Why?
Aged, 80 and over
3
2010
5571
0.160
Why?
Combined Modality Therapy
2
2009
1516
0.150
Why?
Signal Transduction
2
2015
2981
0.140
Why?
Neoplasm Recurrence, Local
1
2017
986
0.130
Why?
Phosphatidylinositol 3-Kinases
1
2012
239
0.130
Why?
Mucositis
1
2010
20
0.130
Why?
Proto-Oncogene Proteins c-akt
1
2012
292
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
1
2010
97
0.120
Why?
Young Adult
2
2013
4505
0.120
Why?
Antigens, CD20
1
2009
39
0.120
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2010
119
0.120
Why?
Pneumonia
1
2010
131
0.120
Why?
Bone Marrow
1
2010
395
0.110
Why?
Drug Synergism
1
2009
311
0.110
Why?
Interferon-alpha
1
2009
234
0.110
Why?
Kaplan-Meier Estimate
1
2010
779
0.100
Why?
Transplantation, Autologous
1
2008
251
0.100
Why?
Thromboembolism
1
2008
101
0.100
Why?
Neoplasms, Second Primary
1
2009
214
0.100
Why?
Recombinant Proteins
1
2009
1009
0.100
Why?
Clinical Trials as Topic
1
2012
1050
0.100
Why?
Topoisomerase I Inhibitors
1
2006
36
0.100
Why?
Procarbazine
1
2006
41
0.090
Why?
Burkitt Lymphoma
1
2006
33
0.090
Why?
Feasibility Studies
1
2008
600
0.090
Why?
Chicago
1
2010
1109
0.090
Why?
Vinblastine
1
2006
106
0.090
Why?
Reoperation
1
2008
531
0.090
Why?
Prednisone
1
2006
246
0.090
Why?
Deoxycytidine
1
2006
236
0.080
Why?
Drug Resistance, Neoplasm
1
2006
453
0.070
Why?
Enzyme Inhibitors
1
2006
638
0.070
Why?
Follow-Up Studies
1
2009
3310
0.070
Why?
Time Factors
1
2006
4894
0.050
Why?
Adolescent
1
2008
7820
0.050
Why?
Smith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_